Jefferies Reiterates Buy on U.S. Physical Therapy

Jefferies is out with its report today on U.S. Physical Therapy USPH, reiterating Buy. In a note to clients, Jefferies writes, "Yesterday's pullback in USPH, in our view, was driven by concerns regarding the impact of a 30% cut in workers' comp rates in Illinois that was finalized on Wednesday night. With only eight out of its ~400 clinics located in IL, USPH has very limited exposure to this drastic rate cut. As such, we would view the stock's recent weakness as a compelling buying opportunity. Reiterate Buy." Jefferies maintains a $28 PT on USPH. Shares of USPH closed Wednesday at $24.01, down 6.72% from Tuesday's close.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorAnalyst RatingsHealth CareHealth Care FacilitiesJefferiesU.S. Physical Therapy
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!